Warfarin Sodium Tablets

This product is a medium-acting anticoagulant of the dicoumarin class. Its mechanism of action is to competitively counteract the effect of vitamin K, inhibit the synthesis of coagulation factors in hepatocytes, and also has the effect of reducing thrombin-induced platelet aggregation reaction, thus having anticoagulant and antiplatelet aggregation functions.

Warfarin sodium.

This product is a sugar-coated tablet, which appears white after removing the sugar coating.

Suitable for patients who need long-term continuous anticoagulation: ① It can prevent the formation and development of blood clots and is used to treat thromboembolic diseases; ② It can treat venous thrombosis after surgery or trauma, and can be used as an auxiliary medication for myocardial infarction; ③ It can be used as a preventive medication for patients who have had thromboembolic diseases and those who are at risk of postoperative thrombotic complications.

Oral administration, common dosage for adults: Avoid shock treatment, take 3-4 mg orally on the first to third days (half the dose is sufficient for the elderly, the weak and diabetic patients), and after three days, give a maintenance dose of 2.5-5 mg per day (the dose can be adjusted with reference to the coagulation time to make the INR value reach 2-3). Because this product takes effect slowly, a transient hypercoagulable state may exist in the first three days of treatment due to the inhibition of plasma anticoagulant protein cells. If an anticoagulant effect is required immediately, heparin can be used at the same time at the beginning, and heparin can be discontinued after this product fully exerts its anticoagulant effect.

Overdose can easily cause various bleeding. Early manifestations include ecchymosis, purpura, gingival bleeding, epistaxis, prolonged wound bleeding, and excessive menstrual flow. Bleeding can occur in any part, especially the urinary and digestive tracts. Intestinal wall hematoma can cause subacute intestinal obstruction, and subdural intracranial hematoma and puncture site hematoma can also be seen. Occasional adverse reactions include nausea, vomiting, diarrhea, itchy rash, allergic reactions and skin necrosis. Large amounts of oral administration may even cause bilateral breast necrosis, microangiopathy or hemolytic anemia, and extensive skin gangrene; excessive doses at one time are especially dangerous.

It is contraindicated in patients with liver and kidney damage, severe hypertension, coagulation disorder with bleeding tendency, active ulcer, trauma, threatened abortion, and recent surgery. It is contraindicated during pregnancy. It should be used with caution in the elderly or during menstruation.

Precautions for children: The dosage should be adjusted according to individual needs. Precautions for pregnancy and lactation: Threatened abortion, prohibited during pregnancy, and should be used with caution during menstruation. Precautions for the elderly: The elderly should use with caution.

Drugs that enhance the anticoagulant effect of this product include: aspirin, sodium salicylate, glucagon, quinidine, indomethacin, phenylbutazone, quinine, uric acid, tolbutamide, metronidazole, allopurinol, erythromycin, chloramphenicol, certain aminoglycoside antibiotics, cephalosporins, beniodarone, cimetidine, clofibrate, dextrothyroxine, acetaminophen, etc. Drugs that reduce the anticoagulant effect of this product include: phenytoin sodium, barbiturates, oral contraceptives, estrogen, cholestyramine, rifampicin, vitamin K, chlorthalidone, spironolactone, primidone, corticosteroids, etc. Drugs that cannot be used in combination with this product include: epinephrine hydrochloride, amikacin, vitamin B12, metaraminolamine, oxytocin, chlorpromazine hydrochloride, vancomycin hydrochloride, etc. When this product is used in combination with chloral hydrate, its efficacy and toxicity are enhanced, so it should be used with caution in a reduced dose. Impaired absorption or decreased synthesis of vitamin K also affects the anticoagulant effect of this product.

Keep away from light and store in sealed container.

2.5mg

24 months.

Qilu Pharmaceutical Co., Ltd.

• Founded in:

  1992-08-21

• Address:

  No. 317, Xinluo Street, High-tech Zone, Jinan City, Shandong Province

• Tax NO.:

  91370000614073351Q

• Registered Funds:

  600 million yuan

• Website:

  Log in to view

• Email:

  Log in to view